Regenerative medicine for back pain can feel confusing. Some clinics promise miracle results from a single injection, while others dismiss biologic treatments as experimental or overhyped. In this episode, we take an evidence-first look at what the science actually says about PRP, stem cells, and regenerative spine care. We start with platelet-rich plasma, or PRP — a biologic treatment made from your own blood. PRP is created by drawing a small blood sample, spinning it in a centrifuge, and concentrating the platelet-rich layer. These platelets contain growth factors and signaling proteins that may help support tissue repair, inflammation control, collagen production, and healing responses. This episode explains why PRP may be relevant for carefully selected patients with chronic discogenic low back pain, including pain believed to come from the spinal disc itself. We also discuss intradiscal PRP, epidural PRP for lumbar disc herniation with radiculopathy, and why PRP works on a different timeline than a steroid injection. Unlike steroids, which often provide short-term inflammation relief, PRP is intended to support a slower biologic healing response over weeks to months. We also take a balanced look at stem cell therapy for spine conditions. Stem cell research is promising, but current marketing often runs ahead of the evidence. You’ll learn why PRP currently has a stronger evidence base in selected spine cases, why patient selection matters, and why regenerative treatments are most likely to help when there is still enough healthy tissue biology left to respond. At Vertrae® in Dayton, Ohio, Dr. Kamal Woods uses an evidence-first, MotionFirst™ approach to evaluate whether regenerative spine care, conservative treatment, interventional pain management, minimally invasive spine surgery, or another targeted option is most appropriate for each patient. No hype. No blanket dismissal. Just a clear conversation about what regenerative medicine may support, where the evidence is still emerging, and who may be the right candidate. Visit Vertrae.com to request your MotionFirst™ evaluation.